prostate tissue array slides Search Results


90
SuperBioChips deparaffinized tissue array slide
Deparaffinized Tissue Array Slide, supplied by SuperBioChips, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pmc04724813-16-2-11?v=SuperBioChips
Average 90 stars, based on 1 article reviews
deparaffinized tissue array slide - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
BioChain Institute human prostate tissue slides
Human Prostate Tissue Slides, supplied by BioChain Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pm32865335-271-0-7?v=BioChain+Institute
Average 90 stars, based on 1 article reviews
human prostate tissue slides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cybrdi Inc prostate tissue microarray slides
Prostate Tissue Microarray Slides, supplied by Cybrdi Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pmc03361642-100-7-13?v=Cybrdi+Inc
Average 90 stars, based on 1 article reviews
prostate tissue microarray slides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
NovoPath Inc formalin- fixed paraffin- embedded lymph node slides
Formalin Fixed Paraffin Embedded Lymph Node Slides, supplied by NovoPath Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pm38189631-23-4-34?v=NovoPath+Inc
Average 90 stars, based on 1 article reviews
formalin- fixed paraffin- embedded lymph node slides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Novus Biologicals prostate tissue array slide
Figure 6 sGCa1 is overexpressed in advanced <t>prostate</t> cancer tissues. (a) Total mRNA was isolated from prostate tissues (acquired from CHTN), which are normal (N1), BPH (B1–B3), or MPC (C1, C2) and subjected to semi-quantitative RT-PCR to measure the expression of sGCa1, sGCb1, PSA, EZH2, E-cadherin, and AR. (b) The human prostate cancer <t>tissue</t> <t>array</t> <t>slide</t> (from Imgenex) was prepared and subjected to immunohistochemistry analysis to detect the expression of sGCa1 protein. Staining results from one or more representative tissues, of different stages, are shown. DAPI staining shows cell nuclei in the lower panels. (c) The sGCa1 expression levels of 45 tissue samples (five normal; eight stages 1 and 2; 32 stages 3 and 4) were quantified according to manufacturer’s protocol (Imgenex). Note that sGCa1 expression levels are represented relative to the average expression level of normal tissues, which was set to 1. Data represent mean expression values plus/minus s.d.
Prostate Tissue Array Slide, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pm16964290-206-0-4?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
prostate tissue array slide - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

99
Olympus vs120 s5 slide scanning system
Figure 6 sGCa1 is overexpressed in advanced <t>prostate</t> cancer tissues. (a) Total mRNA was isolated from prostate tissues (acquired from CHTN), which are normal (N1), BPH (B1–B3), or MPC (C1, C2) and subjected to semi-quantitative RT-PCR to measure the expression of sGCa1, sGCb1, PSA, EZH2, E-cadherin, and AR. (b) The human prostate cancer <t>tissue</t> <t>array</t> <t>slide</t> (from Imgenex) was prepared and subjected to immunohistochemistry analysis to detect the expression of sGCa1 protein. Staining results from one or more representative tissues, of different stages, are shown. DAPI staining shows cell nuclei in the lower panels. (c) The sGCa1 expression levels of 45 tissue samples (five normal; eight stages 1 and 2; 32 stages 3 and 4) were quantified according to manufacturer’s protocol (Imgenex). Note that sGCa1 expression levels are represented relative to the average expression level of normal tissues, which was set to 1. Data represent mean expression values plus/minus s.d.
Vs120 S5 Slide Scanning System, supplied by Olympus, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pmc04876324-121-8-7?v=Olympus
Average 99 stars, based on 1 article reviews
vs120 s5 slide scanning system - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier

90
Novus Biologicals prostate tissues tissue slides
FIGURE 1 – Specific expression of PSGR in human <t>prostate</t> <t>tissues</t> using in situ hybridization. (A) Overexpression of PSGR in human prostate malignant tissues with different clinical stages and Gleason scores. (A-a) Gleason score 7, clinical stage II, T2N0M0. (A-b) Gleason score 4, clinical stage III, T3N0M0. (A-c) Gleason score 9, clinical stage IV, T4NXM1. (A-d) Gleason score 9, clinical stage IV, T3N1M0. (B) PSGR expression in prostate PIN and normal <t>tissue.</t> Strong PSGR expression is noted in varied stages of PIN (arrow) samples, whereas very low amount of PSGR transcripts are evident in adjacent normal prostate tissues (N, arrow). (B-a) Expression of PSGR in tufting pattern of PIN and normal prostate tissue. (B-b) PSGR expression in the micropapillary pattern of PIN lesion. (B-c and B-d) In situ hybridization of PSGR expression using PSGR sense probe as a control. (C) Expression of PSGR in nonprostate malignant tissues. No PSGR expression was detected in other malignant tissues. (C-a) Breast cancer tissue. (C-b) Lung cancer. (C-c) Stomach cancer. (C-d) Uterine cancer tissue.
Prostate Tissues Tissue Slides, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pm15499628-38-6-37?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
prostate tissues tissue slides - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
3DHistech ltd whole-slide image scanner epredia
FIGURE 1 – Specific expression of PSGR in human <t>prostate</t> <t>tissues</t> using in situ hybridization. (A) Overexpression of PSGR in human prostate malignant tissues with different clinical stages and Gleason scores. (A-a) Gleason score 7, clinical stage II, T2N0M0. (A-b) Gleason score 4, clinical stage III, T3N0M0. (A-c) Gleason score 9, clinical stage IV, T4NXM1. (A-d) Gleason score 9, clinical stage IV, T3N1M0. (B) PSGR expression in prostate PIN and normal <t>tissue.</t> Strong PSGR expression is noted in varied stages of PIN (arrow) samples, whereas very low amount of PSGR transcripts are evident in adjacent normal prostate tissues (N, arrow). (B-a) Expression of PSGR in tufting pattern of PIN and normal prostate tissue. (B-b) PSGR expression in the micropapillary pattern of PIN lesion. (B-c and B-d) In situ hybridization of PSGR expression using PSGR sense probe as a control. (C) Expression of PSGR in nonprostate malignant tissues. No PSGR expression was detected in other malignant tissues. (C-a) Breast cancer tissue. (C-b) Lung cancer. (C-c) Stomach cancer. (C-d) Uterine cancer tissue.
Whole Slide Image Scanner Epredia, supplied by 3DHistech ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/us11861881-521-46-67?v=3DHistech+ltd
Average 90 stars, based on 1 article reviews
whole-slide image scanner epredia - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Proteintech pawr
FIGURE 1 – Specific expression of PSGR in human <t>prostate</t> <t>tissues</t> using in situ hybridization. (A) Overexpression of PSGR in human prostate malignant tissues with different clinical stages and Gleason scores. (A-a) Gleason score 7, clinical stage II, T2N0M0. (A-b) Gleason score 4, clinical stage III, T3N0M0. (A-c) Gleason score 9, clinical stage IV, T4NXM1. (A-d) Gleason score 9, clinical stage IV, T3N1M0. (B) PSGR expression in prostate PIN and normal <t>tissue.</t> Strong PSGR expression is noted in varied stages of PIN (arrow) samples, whereas very low amount of PSGR transcripts are evident in adjacent normal prostate tissues (N, arrow). (B-a) Expression of PSGR in tufting pattern of PIN and normal prostate tissue. (B-b) PSGR expression in the micropapillary pattern of PIN lesion. (B-c and B-d) In situ hybridization of PSGR expression using PSGR sense probe as a control. (C) Expression of PSGR in nonprostate malignant tissues. No PSGR expression was detected in other malignant tissues. (C-a) Breast cancer tissue. (C-b) Lung cancer. (C-c) Stomach cancer. (C-d) Uterine cancer tissue.
Pawr, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pmc07737345-83-9-12?v=Proteintech
Average 90 stars, based on 1 article reviews
pawr - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Kaggle Inc panda challenge on kaggle
FIGURE 1 – Specific expression of PSGR in human <t>prostate</t> <t>tissues</t> using in situ hybridization. (A) Overexpression of PSGR in human prostate malignant tissues with different clinical stages and Gleason scores. (A-a) Gleason score 7, clinical stage II, T2N0M0. (A-b) Gleason score 4, clinical stage III, T3N0M0. (A-c) Gleason score 9, clinical stage IV, T4NXM1. (A-d) Gleason score 9, clinical stage IV, T3N1M0. (B) PSGR expression in prostate PIN and normal <t>tissue.</t> Strong PSGR expression is noted in varied stages of PIN (arrow) samples, whereas very low amount of PSGR transcripts are evident in adjacent normal prostate tissues (N, arrow). (B-a) Expression of PSGR in tufting pattern of PIN and normal prostate tissue. (B-b) PSGR expression in the micropapillary pattern of PIN lesion. (B-c and B-d) In situ hybridization of PSGR expression using PSGR sense probe as a control. (C) Expression of PSGR in nonprostate malignant tissues. No PSGR expression was detected in other malignant tissues. (C-a) Breast cancer tissue. (C-b) Lung cancer. (C-c) Stomach cancer. (C-d) Uterine cancer tissue.
Panda Challenge On Kaggle, supplied by Kaggle Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pm41639188-358-27-30?v=Kaggle+Inc
Average 86 stars, based on 1 article reviews
panda challenge on kaggle - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Cybrdi Inc tma slides containing duplicate cores from 40 prostate tissues
FIGURE 1 – Specific expression of PSGR in human <t>prostate</t> <t>tissues</t> using in situ hybridization. (A) Overexpression of PSGR in human prostate malignant tissues with different clinical stages and Gleason scores. (A-a) Gleason score 7, clinical stage II, T2N0M0. (A-b) Gleason score 4, clinical stage III, T3N0M0. (A-c) Gleason score 9, clinical stage IV, T4NXM1. (A-d) Gleason score 9, clinical stage IV, T3N1M0. (B) PSGR expression in prostate PIN and normal <t>tissue.</t> Strong PSGR expression is noted in varied stages of PIN (arrow) samples, whereas very low amount of PSGR transcripts are evident in adjacent normal prostate tissues (N, arrow). (B-a) Expression of PSGR in tufting pattern of PIN and normal prostate tissue. (B-b) PSGR expression in the micropapillary pattern of PIN lesion. (B-c and B-d) In situ hybridization of PSGR expression using PSGR sense probe as a control. (C) Expression of PSGR in nonprostate malignant tissues. No PSGR expression was detected in other malignant tissues. (C-a) Breast cancer tissue. (C-b) Lung cancer. (C-c) Stomach cancer. (C-d) Uterine cancer tissue.
Tma Slides Containing Duplicate Cores From 40 Prostate Tissues, supplied by Cybrdi Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pmc04889721-101-7-12?v=Cybrdi+Inc
Average 90 stars, based on 1 article reviews
tma slides containing duplicate cores from 40 prostate tissues - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Novus Biologicals prostate adenocarcinoma specimens
Fig. 1. Fhl1 and Sdpr expression in normal epi- thelium and tumors from human breast, kidney, and prostate. Immunohistochemical staining was performed on normal and tumor human tissue. Fhl1 and Sdpr staining was evident in normal epithelial cells of the breast, kidney, and prostate. In contrast, both Fhl1 and Sdpr expression were suppressed in infiltrating mammary duct carcinoma, renal cell carcinoma, and prostate <t>adenocarcinoma.</t> (bar = 60 microns).
Prostate Adenocarcinoma Specimens, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prostate+tissue+array+slides/pm18422756-19-18-34?v=Novus+Biologicals
Average 90 stars, based on 1 article reviews
prostate adenocarcinoma specimens - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Figure 6 sGCa1 is overexpressed in advanced prostate cancer tissues. (a) Total mRNA was isolated from prostate tissues (acquired from CHTN), which are normal (N1), BPH (B1–B3), or MPC (C1, C2) and subjected to semi-quantitative RT-PCR to measure the expression of sGCa1, sGCb1, PSA, EZH2, E-cadherin, and AR. (b) The human prostate cancer tissue array slide (from Imgenex) was prepared and subjected to immunohistochemistry analysis to detect the expression of sGCa1 protein. Staining results from one or more representative tissues, of different stages, are shown. DAPI staining shows cell nuclei in the lower panels. (c) The sGCa1 expression levels of 45 tissue samples (five normal; eight stages 1 and 2; 32 stages 3 and 4) were quantified according to manufacturer’s protocol (Imgenex). Note that sGCa1 expression levels are represented relative to the average expression level of normal tissues, which was set to 1. Data represent mean expression values plus/minus s.d.

Journal: Oncogene

Article Title: Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation.

doi: 10.1038/sj.onc.1209956

Figure Lengend Snippet: Figure 6 sGCa1 is overexpressed in advanced prostate cancer tissues. (a) Total mRNA was isolated from prostate tissues (acquired from CHTN), which are normal (N1), BPH (B1–B3), or MPC (C1, C2) and subjected to semi-quantitative RT-PCR to measure the expression of sGCa1, sGCb1, PSA, EZH2, E-cadherin, and AR. (b) The human prostate cancer tissue array slide (from Imgenex) was prepared and subjected to immunohistochemistry analysis to detect the expression of sGCa1 protein. Staining results from one or more representative tissues, of different stages, are shown. DAPI staining shows cell nuclei in the lower panels. (c) The sGCa1 expression levels of 45 tissue samples (five normal; eight stages 1 and 2; 32 stages 3 and 4) were quantified according to manufacturer’s protocol (Imgenex). Note that sGCa1 expression levels are represented relative to the average expression level of normal tissues, which was set to 1. Data represent mean expression values plus/minus s.d.

Article Snippet: Prostate tissue array slide (Imgenex) was processed according to the manufacturer’s protocol.

Techniques: Isolation, Quantitative RT-PCR, Expressing, Immunohistochemistry, Staining

FIGURE 1 – Specific expression of PSGR in human prostate tissues using in situ hybridization. (A) Overexpression of PSGR in human prostate malignant tissues with different clinical stages and Gleason scores. (A-a) Gleason score 7, clinical stage II, T2N0M0. (A-b) Gleason score 4, clinical stage III, T3N0M0. (A-c) Gleason score 9, clinical stage IV, T4NXM1. (A-d) Gleason score 9, clinical stage IV, T3N1M0. (B) PSGR expression in prostate PIN and normal tissue. Strong PSGR expression is noted in varied stages of PIN (arrow) samples, whereas very low amount of PSGR transcripts are evident in adjacent normal prostate tissues (N, arrow). (B-a) Expression of PSGR in tufting pattern of PIN and normal prostate tissue. (B-b) PSGR expression in the micropapillary pattern of PIN lesion. (B-c and B-d) In situ hybridization of PSGR expression using PSGR sense probe as a control. (C) Expression of PSGR in nonprostate malignant tissues. No PSGR expression was detected in other malignant tissues. (C-a) Breast cancer tissue. (C-b) Lung cancer. (C-c) Stomach cancer. (C-d) Uterine cancer tissue.

Journal: International journal of cancer

Article Title: Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.

doi: 10.1002/ijc.20635

Figure Lengend Snippet: FIGURE 1 – Specific expression of PSGR in human prostate tissues using in situ hybridization. (A) Overexpression of PSGR in human prostate malignant tissues with different clinical stages and Gleason scores. (A-a) Gleason score 7, clinical stage II, T2N0M0. (A-b) Gleason score 4, clinical stage III, T3N0M0. (A-c) Gleason score 9, clinical stage IV, T4NXM1. (A-d) Gleason score 9, clinical stage IV, T3N1M0. (B) PSGR expression in prostate PIN and normal tissue. Strong PSGR expression is noted in varied stages of PIN (arrow) samples, whereas very low amount of PSGR transcripts are evident in adjacent normal prostate tissues (N, arrow). (B-a) Expression of PSGR in tufting pattern of PIN and normal prostate tissue. (B-b) PSGR expression in the micropapillary pattern of PIN lesion. (B-c and B-d) In situ hybridization of PSGR expression using PSGR sense probe as a control. (C) Expression of PSGR in nonprostate malignant tissues. No PSGR expression was detected in other malignant tissues. (C-a) Breast cancer tissue. (C-b) Lung cancer. (C-c) Stomach cancer. (C-d) Uterine cancer tissue.

Article Snippet: In situ hybridization of PSGR in prostate tissues Tissue slides containing 56 prostate tumors and 11 nonprostate tumors of varied clinical stages, 6 normal prostate tissues and 11 normal nonprostate tissues embedded in paraffin were bought from IMGENEX.

Techniques: Expressing, In Situ Hybridization, Over Expression, Control

FIGURE 2 – The expression of PSGR mRNA level (copies/103 -ac- tin) in normal prostate tissue (normal, 19), BPH (8) and PCa (57) determined by real-time RT-PCR method. The expression level of PSGR mRNA detected in the prostate tumor tissue is significantly higher than that from the normal prostate tissue and BPH tissue (p 0.001, Mann-Whitney U-test). No significant difference was detected for the expression of PSGR between normal prostate and BPH (p 0.05, Mann-Whitney U-test).

Journal: International journal of cancer

Article Title: Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.

doi: 10.1002/ijc.20635

Figure Lengend Snippet: FIGURE 2 – The expression of PSGR mRNA level (copies/103 -ac- tin) in normal prostate tissue (normal, 19), BPH (8) and PCa (57) determined by real-time RT-PCR method. The expression level of PSGR mRNA detected in the prostate tumor tissue is significantly higher than that from the normal prostate tissue and BPH tissue (p 0.001, Mann-Whitney U-test). No significant difference was detected for the expression of PSGR between normal prostate and BPH (p 0.05, Mann-Whitney U-test).

Article Snippet: In situ hybridization of PSGR in prostate tissues Tissue slides containing 56 prostate tumors and 11 nonprostate tumors of varied clinical stages, 6 normal prostate tissues and 11 normal nonprostate tissues embedded in paraffin were bought from IMGENEX.

Techniques: Expressing, Quantitative RT-PCR, MANN-WHITNEY

FIGURE 3 – ROC for PSGR real-time PCR assay. The assay has high-level sensitivity and specificity for discriminating benign prostate tissue from malignant prostate tissue in laboratory (AUC 0.902 0.032).

Journal: International journal of cancer

Article Title: Increased expression of prostate-specific G-protein-coupled receptor in human prostate intraepithelial neoplasia and prostate cancers.

doi: 10.1002/ijc.20635

Figure Lengend Snippet: FIGURE 3 – ROC for PSGR real-time PCR assay. The assay has high-level sensitivity and specificity for discriminating benign prostate tissue from malignant prostate tissue in laboratory (AUC 0.902 0.032).

Article Snippet: In situ hybridization of PSGR in prostate tissues Tissue slides containing 56 prostate tumors and 11 nonprostate tumors of varied clinical stages, 6 normal prostate tissues and 11 normal nonprostate tissues embedded in paraffin were bought from IMGENEX.

Techniques: Real-time Polymerase Chain Reaction

Fig. 1. Fhl1 and Sdpr expression in normal epi- thelium and tumors from human breast, kidney, and prostate. Immunohistochemical staining was performed on normal and tumor human tissue. Fhl1 and Sdpr staining was evident in normal epithelial cells of the breast, kidney, and prostate. In contrast, both Fhl1 and Sdpr expression were suppressed in infiltrating mammary duct carcinoma, renal cell carcinoma, and prostate adenocarcinoma. (bar = 60 microns).

Journal: Cancer science

Article Title: Coordinate suppression of Sdpr and Fhl1 expression in tumors of the breast, kidney, and prostate.

doi: 10.1111/j.1349-7006.2008.00816.x

Figure Lengend Snippet: Fig. 1. Fhl1 and Sdpr expression in normal epi- thelium and tumors from human breast, kidney, and prostate. Immunohistochemical staining was performed on normal and tumor human tissue. Fhl1 and Sdpr staining was evident in normal epithelial cells of the breast, kidney, and prostate. In contrast, both Fhl1 and Sdpr expression were suppressed in infiltrating mammary duct carcinoma, renal cell carcinoma, and prostate adenocarcinoma. (bar = 60 microns).

Article Snippet: Slides containing 15 infiltrating duct carcinoma specimens with normal adjacent tissue from breast cancer patients (IMH-371, Imgenex), nine prostate adenocarcinoma specimens with adjacent normal tissue and an additional unmatched 41 prostate adenocarcinoma specimens (IMH-303, Imgenex), and nine renal cell carcinoma specimens with adjacent normal tissue and an additional unmatched 31 cell carcinoma specimens (IMH-313, Imgenex) were examined by immunohistochemistry as previously described. (19) Briefly, after removal of paraffin with xylene and rehydration through a graded series of decreasing concentrations of ethanol, protein antigenicity was enhanced by microwaving sections in Target Buffer (Dako, Carpenturia, CA, USA) for 2 min.

Techniques: Expressing, Immunohistochemical staining, Staining